Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Change in Acquisitions & Divestments of $20.0 million for Q1 2026, up 17.63% year-over-year from $17.0 million in Q1 2025, and up 0.83% quarter-over-quarter from $19.8 million in Q4 2025.
Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Collegium Pharmaceutical's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $20.0 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 17.63% year-over-year to $20.0 million; the TTM figure through Mar 2026 stood at $68.2 million (down 22.58% YoY), while the FY2025 annual figure was $65.2 million, down 29.62% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $20.0 million, up from $19.8 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $29.4 million in Q3 2024, with the low at $13.8 million in Q2 2025.
- The 4-year median for Change in Acquisitions & Divestments is $18.4 million (2025), against an average of $19.4 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 24.2% in 2025, while the deepest fall reached 50.49% in 2025.
- Collegium Pharmaceutical's Change in Acquisitions & Divestments stood at $16.0 million in 2023, then declined by 0.15% to $16.0 million in 2024, then grew by 24.2% to $19.8 million in 2025, then climbed by 0.83% to $20.0 million in 2026.
- Business Quant data shows COLL's Change in Acquisitions & Divestments at $20.0 million in Q1 2026, $19.8 million in Q4 2025, and $14.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 131.80 Mn |
| Jun 30, 2026 | 131.80 Mn |
| Mar 31, 2026 | 20.01 Mn |
| Mar 31, 2026 | 20.01 Mn |
| Dec 31, 2025 | 19.84 Mn |
| Dec 31, 2025 | 19.84 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Sep 30, 2025 | 14.57 Mn |
| Jun 30, 2025 | 13.76 Mn |
| Jun 30, 2025 | 13.76 Mn |
| Mar 31, 2025 | 17.01 Mn |
| Mar 31, 2025 | 17.01 Mn |
| Dec 31, 2024 | 15.98 Mn |
| Dec 31, 2024 | 15.98 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Sep 30, 2024 | 29.42 Mn |
| Jun 30, 2024 | 25.66 Mn |
| Jun 30, 2024 | 25.66 Mn |
| Mar 31, 2024 | 21.55 Mn |
| Mar 31, 2024 | 21.55 Mn |